Previous close | 0.0800 |
Open | 0.1000 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 3.00 |
Expiry date | 2024-05-17 |
Day's range | 0.0500 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 352 |
Does Heron Therapeutics (HRTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ionis (IONS) and Biogen (BIIB) stop developing their experimental ALS drug after a phase I/II study failed to show improvement in patients.
Per the FDA, the data submitted by Ascendis (ASND) for its hormone replacement therapy constitutes a major amendment to its previously-submitted data. A final decision is expected by Aug 14.